Clinical Trial Update: A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping [Phase 3]

View source ↗

Summary

Phase 3 trial comparing C Pola R-CHP+X versus CR-CHOP for previously untreated double-expressor diffuse large B-cell lymphoma under genotyping guidance; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Double Expressor Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: Ruijin Hospital | Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Double Expressor Lymphoma | Phase 3 | Status: NOT_YET_RECRUITING